Dong-Moung Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dong-Moung Kim has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Beom Seok Kim
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
1 shared publication - Hyon-Suk Kim
Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
1 shared publication - Jieun Kim
Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea
1 shared publication - Jong Rak Choi
Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
1 shared publication - Myoung Soo Kim
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
1 shared publication - Seung-Hyun Jung
Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 31 December 2021
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 19 (4) , e41
Development of an RNA sequencing panel to detect gene fusions in thyroid cancer
In addition to mutations and copy number alterations, gene fusions are commonly identified in cancers. In thyroid cancer, fusions of important cancer-related genes have been commonly reported; however, extant panels do not cover all clinically important gene fusions. In this study, we aimed to develop a custom RNA-based sequencing panel to identify the key fusions in thyroid cancer. Our ThyChase panel was designed to detect 87 types of gene fusion. As quality control of RNA sequencing, five housekeeping genes were included in this panel. When we applied this panel for the analysis of fusions containing reference RNA (HD796), three expected fusions (EML4-ALK, CCDC6-RET, and TPM3-NTRK1) were successfully identified. We confirmed the fusion breakpoint sequences of the three fusions from HD796 by Sanger sequencing. Regarding the limit of detection, this panel could detect the target fusions from a tumor sample containing a 1% fusion-positive tumor cellular fraction. Taken together, our ThyChase panel would be useful to identify gene fusions in the clinical field.
- 31 December 2021
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 19 (4) , e41
Open AccessDevelopment of an RNA sequencing panel to detect gene fusions in thyroid cancer
In addition to mutations and copy number alterations, gene fusions are commonly identified in cancers. In thyroid cancer, fusions of important cancer-related genes have been commonly reported; however, extant panels do not cover all clinically important gene fusions. In this study, we aimed to develop a custom RNA-based sequencing panel to identify the key fusions in thyroid cancer. Our ThyChase panel was designed to detect 87 types of gene fusion. As quality control of RNA sequencing, five housekeeping genes were included in this panel. When we applied this panel for the analysis of fusions containing reference RNA (HD796), three expected fusions (EML4-ALK, CCDC6-RET, and TPM3-NTRK1) were successfully identified. We confirmed the fusion breakpoint sequences of the three fusions from HD796 by Sanger sequencing. Regarding the limit of detection, this panel could detect the target fusions from a tumor sample containing a 1% fusion-positive tumor cellular fraction. Taken together, our ThyChase panel would be useful to identify gene fusions in the clinical field.
- Open Access
- 1 September 2021
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 41 (5) , 469-478
Expanding the Non-Invasive Diagnosis of Acute Rejection in Kidney Transplants Through Detection of Donor-Derived DNA in Urine: Proof-of-Concept Study
Jieun Kim, M.D., Ph,D., Dong-Moung Kim, B.A., Yu Jin Park, M.D., Ph.D., Seung-Tae Lee, M.D., Ph,D., Hyon-Suk Kim, M.D., Ph,D., Myoung Soo Kim, M.D., Ph.D., Beom Seok Kim, M.D., Ph.D., and Jong Rak Choi, M.D., Ph.D.. Ann Lab Med 2021;41:469-78. https://doi.org/10.3343/alm.2021.41.5.469
- 1 September 2021
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 41 (5) , 469-478
Open AccessExpanding the Non-Invasive Diagnosis of Acute Rejection in Kidney Transplants Through Detection of Donor-Derived DNA in Urine: Proof-of-Concept Study
Jieun Kim, M.D., Ph,D., Dong-Moung Kim, B.A., Yu Jin Park, M.D., Ph.D., Seung-Tae Lee, M.D., Ph,D., Hyon-Suk Kim, M.D., Ph,D., Myoung Soo Kim, M.D., Ph.D., Beom Seok Kim, M.D., Ph.D., and Jong Rak Choi, M.D., Ph.D.. Ann Lab Med 2021;41:469-78. https://doi.org/10.3343/alm.2021.41.5.469